DNA methylation in repeat negative prostate biopsies as a marker of missed prostate cancer.
Valentina FianoDaniela ZugnaChiara GrassoMorena TrevisanLuisa DelsedimeLuca MolinaroPaola CassoniMauro PapottiFranco MerlettiOlof AkreAndreas PetterssonLaura De MarcoLorenzo RichiardiPublished in: Clinical epigenetics (2019)
Our results suggest that GSTP1 methylation in negative prostate biopsies is stable over time and can predict missed cancer with high specificity.